Xenetic Biosciences Inc.
XBIO | NASDAQ
$2.47
-$0.52 (-17.39%)
Sep 22, 2026, 2:34 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -929.7K | -456.38K | -579.08K | -509.94K | -688.7K | -903.14K | -1.05M | -436.67K | -1.27M | -1.2M | -1.17M | -1.06M | -1.05M | -856.55K | -1.48M | -804.02K | -2.67M | -1.59M | -1.84M | -1.35M | -1.11M | -1.35M |
Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 7.96K | 9.61K | 9.48K | 9.28K | 9.04K | 8.75K | 8.41K |
Stock-Based Compensation | 63.28K | n/a | 14K | n/a | 15.68K | 19.25K | 25.11K | 27.54K | 42.1K | 77.07K | 74.58K | 70.27K | 69.39K | 68.85K | 118.65K | 137.36K | 135.87K | 119.6K | 113.1K | 111.13K | 109.92K | 76.28K |
Other Working Capital | 81.52K | -81.52K | 466.15K | -372.51K | 53.69K | 108.33K | 470.57K | 528.29K | -164.34K | 51.79K | 562.81K | -161.53K | -302.5K | -97.95K | 101.93K | -192.25K | 276.89K | -265.32K | -39.01K | 42.01K | 110.79K | -109.73K |
Other Non-Cash Items | -100.38K | 11.31K | n/a | 15.85K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 488.75K | 381.6K | 1.31M | n/a | n/a | n/a | n/a | n/a |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -381.6K | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 91.31K | -91.31K | 322.4K | -164.16K | 289.19K | -118K | 355.42K | -49.9K | 706.77K | -41.31K | 303.9K | 35.66K | -287.55K | -314.74K | 124.23K | -420.57K | 492.81K | -623.15K | 260.6K | 197.34K | 261.2K | -257.94K |
Operating Cash Flow | -875.49K | -536.38K | -242.68K | -658.25K | -383.83K | -1M | -673.99K | -459.04K | -525.1K | -1.16M | -793.03K | -949.63K | -1.27M | -1.1M | -750.91K | -1.08M | -728.9K | -2.09M | -1.46M | -1.03M | -726.81K | -1.52M |
Capital Expenditures | 3 | -3 | n/a | -3 | n/a | 2 | n/a | n/a | n/a | n/a | n/a | 4 | n/a | -2 | n/a | n/a | -1 | n/a | -1 | n/a | n/a | -2 |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -500K | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -500K | n/a | n/a | n/a | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Financial Cash Flow | n/a | n/a | 4M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 11.45M | n/a | n/a |
Net Cash Flow | -875.49K | -536.38K | 3.76M | -658.25K | -383.83K | -1M | -673.99K | -459.04K | -525.1K | -1.16M | -793.03K | -949.63K | -1.27M | -1.1M | -750.91K | -1.08M | -1.23M | -2.09M | -1.46M | 10.42M | -726.81K | -1.52M |
Free Cash Flow | -875.49K | -536.38K | -242.68K | -658.25K | -383.83K | -1M | -673.99K | -459.04K | -525.1K | -1.16M | -793.03K | -949.63K | -1.27M | -1.1M | -750.91K | -1.08M | -728.9K | -2.09M | -1.46M | -1.03M | -726.81K | -1.52M |
Adj. Free Cash Flow | -938.76K | -536.38K | -256.68K | -658.25K | -399.51K | -1.02M | -699.1K | -486.57K | -567.2K | -1.24M | -867.61K | -1.02M | -1.34M | -1.17M | -869.56K | -1.22M | -864.77K | -2.21M | -1.57M | -1.14M | -836.73K | -1.6M |
Maintenance CapEx | n/a | n/a | n/a | n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | 8 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Growth CapEx | 3 | -3 | n/a | -3 | n/a | -2 | n/a | n/a | n/a | n/a | n/a | -4 | n/a | -2 | n/a | n/a | -1 | n/a | -1 | n/a | n/a | -2 |
Owner Earnings | -875.49K | -536.38K | -242.68K | -658.25K | -383.83K | -1M | -673.99K | -459.04K | -525.1K | -1.16M | -793.03K | -949.63K | -1.27M | -1.1M | -750.91K | -1.08M | -728.9K | -2.09M | -1.46M | -1.03M | -726.81K | -1.52M |
Add to Watchlist
Select watchlists to add or remove XBIO